{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:11:57Z","timestamp":1793664717124,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaad.2020.11.037","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T02:24:23Z","timestamp":1606443863000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"85","author":[{"given":"Nina H.","family":"Ravn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra F.","family":"Ahmadzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine A.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik H.P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"R\u00e6vdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sofie","family":"Halling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.11.037_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.11.037_bib2","doi-asserted-by":"crossref","first-page":"e39803","DOI":"10.1371\/journal.pone.0039803","article-title":"Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies","volume":"7","author":"Deckers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.11.037_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.17766","article-title":"Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide","volume":"181","author":"Irvine","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.11.037_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2017.03.003","article-title":"Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis","volume":"77","author":"Thyssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaip.2018.10.009","article-title":"Atopic dermatitis is associated with increased prevalence of multiple ocular comorbidities","volume":"7","author":"Govind","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2020.11.037_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5021\/ad.2019.31.1.37","article-title":"Cataract, glaucoma, and dry eye disease in adults with atopic dermatitis: a nationwide cross-sectional study from the Republic of Korea","volume":"31","author":"Lee","year":"2019","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.11.037_bib9","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.11.037_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bjophthalmol-2019-315010","article-title":"Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment","volume":"104","author":"Nahum","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2020.11.037_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.18176\/jiaci.0481","article-title":"Dupilumab-associated conjunctivitis in patients with atopic dermatitis: a multicenter real-life experience","volume":"30","author":"Nettis","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaad.2020.11.037_bib14","article-title":"Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: a multi-institution retrospective chart review","author":"Waldman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamadermatol.2018.2690","article-title":"Risk factors for dupilumab-associated conjunctivitis in patients with atopic dermatitis","volume":"154","author":"Treister","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2340\/00015555-3121","article-title":"Eye complications during dupilumab treatment for severe atopic dermatitis","volume":"99","author":"Ivert","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.11.037_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40123-019-0191-9","article-title":"Ocular surface diseases induced by dupilumab in severe atopic dermatitis","volume":"8","author":"Maudinet","year":"2019","journal-title":"Ophthal Ther"},{"key":"10.1016\/j.jaad.2020.11.037_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE)","volume":"78","author":"Simpson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.11.037_bib20","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2020.11.037_bib21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/sim.2287","article-title":"Four-fold table cell frequencies imputation in meta analysis","volume":"25","author":"Di Pietrantonj","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.jaad.2020.11.037_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/all.14080","article-title":"Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry","volume":"75","author":"Ariens","year":"2020","journal-title":"Allergy"},{"issue":"Suppl 106","key":"10.1016\/j.jaad.2020.11.037_bib23","first-page":"183","article-title":"Dupilumab-related blepharoconjunctivitis in patients with severe atopic dermatitis","volume":"74","author":"Doan","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2020.11.037_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2019.02.053","article-title":"Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort","volume":"81","author":"Faiz","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib25","article-title":"Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis","author":"Fargnoli","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2020.11.037_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2019.10.010","article-title":"Off-label use of dupilumab for pediatric patients with atopic dermatitis: a multicenter retrospective review","volume":"82","author":"Igelman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jdv.15609","article-title":"Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre","volume":"33","author":"Olesen","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.11.037_bib28","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/jdv.15118","article-title":"Dupilumab: short-term effectiveness and security in real clinical practice\u2014a retrospective multicentric study","volume":"33","author":"Ruiz-Villaverde","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.11.037_bib29","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/bjd.17629","article-title":"Effect of dupilumab on\u00a0atopic manifestations in patients treated for atopic\u00a0dermatitis in real-life practice","volume":"180","author":"Tauber","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jaad.2019.12.039","article-title":"Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of IgE and TARC but not clinical severity in a real-world setting","volume":"82","author":"Uchida","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bjd.18179","article-title":"Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data","volume":"182","author":"de Wijs","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/abd1806-4841.20175140","article-title":"Particular characteristics of atopic eczema in tropical environments. The Tropical Environment Control for Chronic Eczema and Molecular Assessment (TECCEMA) cohort study","volume":"92","author":"Sanchez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor a antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.11.037_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/bjd.18476","article-title":"Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension","volume":"182","author":"Cork","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/ICU.0000000000000532","article-title":"Ocular involvement in atopic disease: a review","volume":"29","author":"Patel","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jaad.2020.11.037_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-019-00455-5","article-title":"Ocular co-morbidities of atopic dermatitis. Part I: associated ocular diseases","volume":"20","author":"Beck","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multimorbidity: many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.11.037_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ACI.0b013e328357a21b","article-title":"Molecular immunology of allergic\u00a0conjunctivitis","volume":"12","author":"Irkec","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 78","key":"10.1016\/j.jaad.2020.11.037_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00570.x","article-title":"Atopic keratoconjunctivitis","volume":"59","author":"Bonini","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2020.11.037_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.11.037_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","article-title":"The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases","volume":"13","author":"Mantelli","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.11.037_bib42","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0161-6420(00)00406-1","article-title":"A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis","volume":"107","author":"Nakata","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2020.11.037_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.11.037_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaophthalmol.2013.6277","article-title":"Association between\u00a0atopy and herpetic eye disease: results from the Pacific Ocular Inflammation Study","volume":"132","author":"Borkar","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaad.2020.11.037_bib45","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.18240\/ijo.2019.11.17","article-title":"The correlation between keratoconus and eye rubbing: a review","volume":"12","author":"Najmi","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jaad.2020.11.037_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ICO.0000000000002150","article-title":"The prevalence and risk factors for keratoconus: a systematic review and meta-analysis","volume":"39","author":"Hashemi","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jaad.2020.11.037_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0161-6420(94)31219-X","article-title":"Retinal detachment with atopic dermatitis similar to traumatic retinal detachment","volume":"101","author":"Oka","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2020.11.037_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1346-8138.1999.tb02068.x","article-title":"Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid","volume":"26","author":"Taniguchi","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib49","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/eye.2017.151","article-title":"Retinal detachment repair and cataract surgery in patients with atopic dermatitis","volume":"31","author":"Jothi","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.jaad.2020.11.037_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.intimp.2017.11.031","article-title":"Adverse events of dupilumab in adults with moderate-to-severe atopic dermatitis: a meta-analysis","volume":"54","author":"Ou","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaad.2020.11.037_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","article-title":"Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis","volume":"84","author":"Halling","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.17538","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib54","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/bjd.16330","article-title":"Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?","volume":"178","author":"Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib55","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaad.2019.01.090","article-title":"Limitations of generalizability and reproducibility of systematic reviews in dermatology","volume":"81","author":"Yew","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2133.2006.07372.x","article-title":"Remembering childhood atopic dermatitis as an adult: factors that influence recollection","volume":"155","author":"Moberg","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib57","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2340\/00015555-2128","article-title":"Recall bias in childhood atopic diseases among adults in the Odense Adolescence Cohort Study","volume":"95","author":"Mortz","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.11.037_bib58","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/bjd.14031","article-title":"Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study","volume":"173","author":"Silverberg","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.11.037_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-139-1-200307010-00006","article-title":"Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination","volume":"139","author":"Naleway","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2020.11.037_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1939-4551-6-4","article-title":"Recognition of allergic conjunctivitis in patients with allergic rhinitis","volume":"6","author":"Williams","year":"2013","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaad.2020.11.037_bib61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jtos.2020.08.005","article-title":"Characterising the ocular surface and tear film in a population-based birth cohort of 45-year old New Zealand men and women","volume":"18","author":"Craig","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jaad.2020.11.037_bib62","first-page":"1815","article-title":"Differential diagnosis of the swollen red eyelid","volume":"76","author":"Papier","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2020.11.037_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2415-14-43","article-title":"Prevalence of infectious keratitis in Central China","volume":"14","author":"Cao","year":"2014","journal-title":"BMC Ophthalmol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220330772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220330772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:07Z","timestamp":1759273087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220330772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0190962220330772"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.037","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}